Hsbc Holdings PLC Sells 43,003 Shares of The Clorox Company $CLX

Hsbc Holdings PLC reduced its holdings in shares of The Clorox Company (NYSE:CLX) by 9.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 399,264 shares of the company’s stock after selling 43,003 shares during the quarter. Hsbc Holdings PLC’s holdings in Clorox were worth $40,332,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of CLX. State Street Corp raised its holdings in Clorox by 3.5% during the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after acquiring an additional 282,794 shares during the period. Invesco Ltd. raised its stake in shares of Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after purchasing an additional 884,751 shares during the period. Geode Capital Management LLC lifted its holdings in Clorox by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock worth $318,613,000 after purchasing an additional 10,060 shares in the last quarter. Van ECK Associates Corp boosted its stake in Clorox by 15.7% in the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock worth $316,244,000 after purchasing an additional 426,433 shares during the period. Finally, Two Sigma Investments LP increased its position in shares of Clorox by 33.8% during the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after buying an additional 439,797 shares during the period. 78.53% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CLX has been the subject of several recent analyst reports. Royal Bank Of Canada reduced their price objective on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. TD Cowen raised their price target on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a report on Tuesday, March 31st. Evercore restated an “underperform” rating and set a $110.00 price target on shares of Clorox in a research report on Friday, May 1st. UBS Group lowered their price objective on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. Finally, BNP Paribas Exane dropped their price objective on Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research note on Tuesday, May 12th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Reduce” and a consensus target price of $103.40.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Clorox Price Performance

Shares of NYSE:CLX opened at $97.15 on Monday. The company’s fifty day moving average price is $94.22 and its 200-day moving average price is $104.24. The firm has a market capitalization of $11.75 billion, a price-to-earnings ratio of 15.77, a PEG ratio of 0.46 and a beta of 0.54. The Clorox Company has a one year low of $84.70 and a one year high of $132.03. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the business earned $1.45 earnings per share. The firm’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.